封面
市場調查報告書
商品編碼
2084726

生物醫用材料市場:按材料類型、應用、最終用戶和地區分類

Biomedical Materials Market, By Material Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2026年,生物醫學材料市場規模將達到824億美元,到2033年將達到1,378億美元。預計從2026年到2033年,該市場將以7.6%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 824億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.60% 2033年市場規模預測: 1378億美元

生物醫用材料市場是全球醫療保健產業的重要組成部分。生物醫用材料是指用於生物系統內長期或特定醫療功能植入且不會引起不良反應的材料。全球生物醫用材料涵蓋多種聚合物、金屬、陶瓷、複合材料和天然生物材料,廣泛應用於植入、藥物傳輸裝置、組織工程支架、診斷工具、傷口敷料、再生醫學等領域。生物相容性確保生物醫用材料在體內有效發揮作用,且不會產生有害影響。

慢性病盛行率的不斷上升、老年人口的成長以及對先進微創治療的需求,正在推動市場成長。材料科學領域的研究與開發為創新材料的發現做出了重大貢獻。奈米技術、智慧材料和生物可分解聚合物的進步,正在拓展生物醫學材料的應用領域,提升其性能,增強病患安全性,並確保與下一代醫療器材的兼容性。

市場動態

全球生物醫學材料市場正受到人口快速老化、慢性病發病率上升以及醫療設備、植入和療法的廣泛應用等因素的推動,這些因素都對生物醫學材料的需求日益成長。材料科學領域的創新,包括智慧生醫材料、奈米技術和可生物分解聚合物,正在拓展其應用範圍,並帶來更佳的治療效果。醫療保健支出的成長和支持醫療發展的政策也促進了市場的快速成長。

然而,生物材料市場的成長受到許多因素的限制,例如嚴格且漫長的法規核准流程、高成本以及複雜的生產流程。生物相容性、長期性能和安全性等挑戰也將限制某些材料和應用的發展。儘管如此,由於開發中國家醫療設施的擴建、個人化醫療需求的成長、組織工程和再生醫學領域應用的拓展、智慧材料的研發以及智慧功能性生物材料在先進療法中的應用等因素,生物材料市場仍蘊藏著巨大的成長潛力。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球生物醫學材料市場主要參與者的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球生物醫學材料市場報告的目標受群眾外包括行業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球生物醫學材料市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章 全球生物醫學材料市場:依材料類型分類,2021-2033年

  • 以聚合物為基礎的生物材料
  • 金屬生物材料
  • 陶瓷生物材料
  • 天然生物材料

第5章 全球生物醫學材料市場:依應用領域分類,2021-2033年

  • 整形外科應用
  • 心血管應用
  • 牙科用途
  • 創傷治療及組織工程
  • 其他

第6章 全球生物醫學材料市場:依最終使用者分類,2021-2033年

  • 醫院
  • 專科診所
  • 研究和學術機構
  • 其他

第7章 全球生物醫學材料市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • Evonik Industries AG
  • DSM-Firmenich
  • Corbion NV
  • BASF SE
  • Covestro AG
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Victrex plc
  • CeramTec GmbH
  • Mitsubishi Chemical Group Corporation

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9596

Biomedical Materials Market is estimated to be valued at USD 82.4 Bn in 2026 and is expected to reach USD 137.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 82.4 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.60% 2033 Value Projection: USD 137.8 Bn

The biomedical materials market is an important segment of the global healthcare industry, defined as the materials that are intended to be placed within a biological system for an extended period or for a specific medical function, without eliciting any undesirable reaction, are known as biomedical materials. The global biomedical materials include different polymers, metals, ceramics, composites, and natural biomaterials used as implants, drug delivery devices, tissue engineering scaffolds, diagnostic tools, wound dressing products and regenerative medicine. Biocompatibility ensures that the biomedical materials work efficiently within the body and do not produce adverse effects.

The factors such as growing prevalence of chronic diseases, increase in elderly population and demand for advanced and minimally invasive treatment approaches drive the growth of the market. Research and development in materials science have contributed significantly toward innovative material discoveries, and advancements like nanotechnology, smart materials and biodegradable polymers broaden the area of application for biomedical materials and improve their performance, while also enhancing patient safety, and making them compatible for next generation devices.

Market Dynamics

The global biomedical materials market is driven by rapidly aging global population, the increasing incidence of chronic diseases and the rising use of medical devices, implants and treatments, which require an increasing number of biomedical materials. Innovations in material science, including smart biomaterials, nanotechnology, and biodegradable polymers are widening their scope of use and are leading to better treatment outcomes. Increasing healthcare expenditure and supportive healthcare development policies are contributing to the rapid market growth.

However, the growth of biomedical materials market is limited by factors such as stringent and protracted regulatory approval processes, high cost of research and development and complex manufacturing processes. Issues such as biocompatibility of the material, long-term performance and safety concerns of materials will limit the growth of some materials and applications. Nevertheless, there are abundant growth prospects due to factors such as expansion of healthcare facilities in developing economies, the growing demand for personalized medicine, wider applications in tissue engineering and regenerative medicine, development of smart materials, and use of smart and functional biomaterials in advanced treatments.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biomedical materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, DSM-Firmenich, Corbion N.V., BASF SE, Covestro AG, Zimmer Biomet Holdings, Inc., Stryker Corporation, Victrex plc, CeramTec GmbH, and Mitsubishi Chemical Group Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biomedical materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomedical materials market

Market Segmentation

  • Material Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Polymeric Biomaterials
  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Orthopedic Applications
  • Cardiovascular Applications
  • Dental Applications
  • Wound Healing and Tissue Engineering
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Research and Academic Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Evonik Industries AG
  • DSM-Firmenich
  • Corbion N.V.
  • BASF SE
  • Covestro AG
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Victrex plc
  • CeramTec GmbH
  • Mitsubishi Chemical Group Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biomedical Materials Market, By Material Type
    • Global Biomedical Materials Market, By Application
    • Global Biomedical Materials Market, By End User
    • Global Biomedical Materials Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Biomedical Materials Market, By Material Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ceramic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Biomedical Materials Market, By Application, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Orthopedic Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiovascular Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Dental Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Wound Healing and Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Biomedical Materials Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Biomedical Materials Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DSM-Firmenich
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Victrex plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CeramTec GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mitsubishi Chemical Group Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us